Systematic Reviews of Drug Treatments for Eye Diseases and Vision Impairments

Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of drug treatments for low vision conditions.
Reviewed May 2012

Printer friendly page Printer friendly page

41 Resources Found

Results 1 to 20 displayed.     1  2  3 

Title:   Corticosteroids for treating optic neuritis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Optic neuritis is an inflammatory disease of the optic nerve characterized by sudden vision loss over several hours or days. The objective of this review was to assess the effectiveness of corticosteroids for acute optic neuritis. We included six random...
Date:   Feb 2012
Title:   Botulinum toxin for the treatment of strabismus
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Strabismus is a condition in which the eyes are out of alignment; one eye may turn inwards, outwards, upwards or downwards. Strabismus may develop in childhood or may be acquired as an adult. Treatment options include eye therapy, glasses, prisms, occlu...
Date:   Dec 2011
Title:   Surgical removal of bony wall or orbital fat for thyroid eye disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Thyroid eye disease is an autoimmune disorder affecting 30% to 50% of patients with Graves' disease. Severe forms present in 3% to 5% of patients with reduced vision due to pressure on the optic nerve. The disease is more frequent in women and it signif...
Date:   Oct 2011
Title:   Melatonin for sleep disorders in visually impaired children
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Melatonin is widely used for management of sleep disorders in children with poor or no vision. The current review planned to examine studies on the use of melatonin in these children to determine whether this drug is effective for improving their sleep ...
Date:   Sep 2011
Title:   Medical interventions for fungal infection of the clear front part of the eye (cornea)
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Fungal keratitis (fungal infection of the cornea) occurs rarely in higher income countries but is relatively common in lower income countries. If left untreated the cornea may perforate and may lead to blindness. Although there are a number of medicatio...
Date:   Aug 2011
Title:   Non-steroidal anti-inflammatory drugs for treating fluid accumulation in the macula after cataract surgery
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cystoid macular oedema (CMO) is the accumulation of fluid in the macula (central retina) due to leakage from capillaries. Clinically significant CMO following cataract surgery is a complication of unknown cause. Acute CMO, defined as oedema of less than...
Date:   Aug 2011
Title:   Interventions for Mooren's ulcer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Mooren's ulcer is inflammation that occurs at the edge of the cornea (clear part of the front of the eye). Its cause is unknown. It is very painful and can or will lead to loss of vision if untreated. It occurs worldwide and affects all age groups. It i...
Date:   Apr 2011
Title:   Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Postoperative vitreous cavity haemorrhage (POVCH) is a significant complication following vitrectomy (removal of the vitreous gel from the posterior chamber of the eye) for the treatment of proliferative retinopathy (the growth of abnormal blood vessels...
Date:   Mar 2011
Title:   Antibiotics compared with no treatment or placebo for the treatment of toxoplasma retinochoroiditis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Toxoplasma retinochoroiditis occurs when a parasite called toxoplasma gondii gets into the retina (the light sensitive layer inside the eye) and the choroid (layer of the eyeball near the retina). This causes inflammation that can scar the retina and re...
Date:   Feb 2011
Title:   Sublingual immunotherapy (tablets, spray or drops under the tongue) to treat inflammation of the conjunctiva due to allergy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Conjunctivitis means inflammation of the conjunctiva. The conjunctiva is the thin 'skin' that covers the white part of the eyes and the inside of the eyelids. Allergic conjunctivitis is the inflammation of the conjunctiva due to allergy. The most common...
Date:   Jan 2011
Title:   Antibiotics reduce the prevalence of ocular infection with trachoma
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Trachoma is common in people living in poor communities and is the most common infectious cause of vision loss. Repeated bouts of conjunctivitis (inflammation of the membranes of the eyes) caused by Chlamydia infection eventually lead to scarring and in...
Date:   Dec 2010
Title:   Steroids in the treatment of traumatic optic neuropathy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   The optic nerve transmits visual information from the eye to the brain and traumatic optic neuropathy (TON) refers to any injury to the optic nerve secondary to trauma. After the optic nerve has been injured, it becomes more swollen and this can lead to...
Date:   Nov 2010
Title:   Antivirals, interferon, and debridement treatments for herpes simplex eye disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Ocular herpes is a prevalent and recurrent eye infection. Without therapy, only one half of non-complicated herpetic corneal surface infections resolve in two weeks. Several treatments, ranging from medications to superficial wiping, aim to shorten the ...
Date:   Oct 2010
Title:   Anti-vascular endothelial growth factor for macular edema secondary to central vein occlusion
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Central retinal vein occlusion (CRVO) is thought to affect between one and four people per thousand at any one time, and is associated with increasing age, high blood pressure, diabetes, glaucoma and various disorders of the blood. It frequently causes ...
Date:   Aug 2010
Title:   Medical interventions for traumatic hyphema
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Traumatic hyphema is the entry of blood into the space between the cornea and iris following a blow or a projectile striking the eye. Along with the appearance of blood, there may be one or more major injuries to the eye from the trauma, which could res...
Date:   Jun 2010
Title:   Neuroprotection for treatment of glaucoma in adults
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Glaucoma is a leading cause of blindness worldwide. It is classified as a group of conditions characterized by progressive damage to the optic nerve, deterioration of retinal ganglion cells and ultimately visual field loss. With regards to glaucoma, neu...
Date:   Jan 2010
Title:   Ivermectin for river blindness (onchocerciasis)
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Onchocerciasis is caused by tiny worms and is transmitted from person to person by a small biting fly. The fly breeds in fast flowing rivers and streams mainly in West Africa. The disease causes severe itching and thickening of the skin and damages stru...
Date:   Aug 2009
Title:   Treatment of amblyopia (lazy eye) with patching or drops/drug treatment
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Amblyopia (referred to as lazy eye) is a common childhood condition, and is defined as defective visual acuity in one or both eyes, which is present with no demonstrable abnormality of the visual pathway and is not immediately resolved by wearing glasse...
Date:   Jun 2009
Title:   Statins for delaying the onset and progression of age-related macular degeneration
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Age-related macular degeneration (AMD) is a progressive late onset disorder of the macula affecting central vision. Studies have shown that some of the factors that may lead to atherosclerosis and strokes are the same as those which may lead to AMD. Sta...
Date:   Sep 2011
Title:   Photodynamic therapy for treating age-related macular degeneration
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Photodynamic therapy involves injecting a photosensitive chemical (verteporfin) into the blood stream then radiating light onto the affected area of the retina as the chemical flows through the eye. The chemical is activated enough to treat neovascular ...
Date:   Apr 2009

Results 1 to 20 displayed.     1  2  3